B Bausch Plus Lomb Corp.
| Market Cap | $5.86B |
| P/E Ratio | — |
| Forward P/E | 15.40 |
| Dividend Yield | — |
| Beta | 0.65 |
| 52W Range | $10.90 - $18.60 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 3 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Howard Marks Oaktree Capital Management | 0.82% | $57.78M | 3,382,739 | Add 4.23% |
| Carl Icahn Icahn Carl C | 0.71% | $59.78M | 3,500,000 | — |
| Lee Ainslie Maverick Capital | 0.03% | $2.60M | 152,183 | Reduce 14.39% |
Insider Trading
| Insider Name of the company insider who made the trade 9 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Eldessouky SamEVP and CFO | Buy | 4,000 | $17.13 | $68.52K | 06 Mar 2026 | 06 Mar 2026 |
| SAUNDERS BRENT LCEO and Chairman of the Board | Buy | 14,700 | $17.14 | $251.96K | 06 Mar 2026 | 06 Mar 2026 |
| Bailey A Robert DEVP & Chief Legal Officer | Buy | 14,600 | $17.15 | $250.33K | 06 Mar 2026 | 06 Mar 2026 |
| Ross Thomas W. Sr. | Buy | 4,500 | $17.68 | $79.56K | 03 Mar 2026 | 04 Mar 2026 |
| Alfonso Eduardo | Buy | 4,300 | $17.90 | $76.97K | 02 Mar 2026 | 03 Mar 2026 |
| VON ESCHENBACH ANDREW C. | Buy | 4,364 | $18.31 | $79.88K | 27 Feb 2026 | 03 Mar 2026 |
| COLLIS STEVEN H | Buy | 15,000 | $17.81 | $267.15K | 23 Feb 2026 | 24 Feb 2026 |
| ROBERTSON RUSSEL C | Buy | 4,400 | $17.90 | $78.76K | 20 Feb 2026 | 24 Feb 2026 |
| Ling Karen | Buy | 4,000 | $17.74 | $70.97K | 19 Feb 2026 | 23 Feb 2026 |
Frequently Asked Questions
What is BLCO stock price today?
Bausch Plus Lomb Corp. (BLCO) is currently trading at $16.49. The stock has a 52-week range of $10.90 to $18.60 and a market capitalization of $5.86B.
Is BLCO a good stock to buy in 2026?
Bausch Plus Lomb Corp. has a P/E ratio of N/A (forward P/E: 15.4), a dividend yield of none, and 1-year performance of +26.9%. 3 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BLCO stock?
There have been 9 insider transactions for BLCO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BLCO stock performed over the past year?
Bausch Plus Lomb Corp. (BLCO) has returned +26.9% over the past 12 months. The stock traded between $10.90 and $18.60 during this period, and is currently at $16.49.
Which hedge funds own BLCO (Bausch Plus Lomb Corp.)?
3 tracked hedge funds currently hold BLCO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BLCO's market cap and valuation?
Bausch Plus Lomb Corp. (BLCO) has a market capitalization of $5.86B. The trailing P/E ratio is N/A and forward P/E is 15.4. The stock is classified in the Healthcare sector.
What is BLCO's revenue and profitability?
Bausch Plus Lomb Corp. reported revenue of $5.10B with net income of N/A and a profit margin of N/A. The stock has a beta of 0.65.
What sector is BLCO in and who are its biggest institutional holders?
Bausch Plus Lomb Corp. (BLCO) operates in the Healthcare sector. It is held by 3 tracked hedge funds. See the ownership table above for the complete list.